CLINICAL_TRIALS
trial_result
· 2021-04-22
Clinical Trial Update: Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma [Phase 2]
Summary
A Phase 2 trial evaluating pembrolizumab with or without radiation in recurrent or metastatic adenoid cystic carcinoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Adenoid Cystic Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-04-22